Rapid Administration of High-Dose Intravenous Methylprednisolone Improves Visual Outcomes After Optic Neuritis in Patients With AQP4-IgG-Positive NMOSD
Tetsuya Akaishi(Tohoku University Hospital), Ichiro Nakashima(Tohoku Medical and Pharmaceutical University), Noriko Himori(Tohoku University), Ryo Ogawa(Fukushima Medical University), Toru Nakazawa(Tohoku University), Toshiyuki Takahashi(Fukushima Medical University), Takayuki Takeshita(Tohoku University), Tatsuro Misu(Tohoku University), Kimihiko Kaneko(Tohoku University), Kazuo Fujihara(Tohoku University), Masashi Aoki(Tohoku University), Michiaki Abe(Tohoku University Hospital), Juichi Fujimori(Fukushima Medical University), Tadashi Ishii(Tohoku University Hospital)
Cited by 48
Related Papers
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
|Annals of Neurology|2011|9.8k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
International consensus diagnostic criteria for neuromyelitis optica spectrum disorders
|Neurology|2015|4.6k
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
|The Lancet|2004|3.2k
MOG encephalomyelitis: international recommendations on diagnosis and antibody testing
|Journal of Neuroinflammation|2018|740